Trials / Unknown
UnknownNCT02908204
Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma
Long-term Outcomes After Treatment for Superficial Esophageal Squamous Cell Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,800 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Tumor is the primary public health problem and the incidence of esophageal cancer showed the increasing trend in the past thirty years. According to the statistics in 2015, the new onset of esophageal cancer is about 477,900 yearly. The mainly pathologic type of esophageal cancer in China is esophageal squamous cell carcinomas, which accounts for more than 90% of patients in China. With the development of endoscopic technics, more and more patients choose to receive the endoscopic procedure rather than traditional surgery. However, the long-term efficacy and outcomes of patients with superficial esophageal squamous cell carcinoma received different interventions remained unclear. Thus, investigators aim to conduct a multi-center retrospective study to investigate the long term outcomes of superficial esophageal squamous cell carcinoma patients receiving endoscopic treatment and surgery.
Conditions
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-10-01
- First posted
- 2016-09-20
- Last updated
- 2016-09-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02908204. Inclusion in this directory is not an endorsement.